| Title | Author | Year | SCOPUS | PUBMED | ISI | TCI | |
|---|---|---|---|---|---|---|---|
| 1. | The efficacy of topiramate in status epilepticus, experience from Thailand | Tiamkao, S. Sawanyawisuth, K. |
2012 | ||||
| 2. | Cost Utility Analysis of Biliary Drainage and Palliative Care in Unresectable Hilar Cholangiocarcinoma: Decision Analytic Modeling Approach | Tanita Suttichaimongkol Apichat Sangchan Pisaln Mairiang |
2015 | ||||
| 3. | Cost utility analysis of palliative biliary drainage compare with palliative care in unresectable hilar cholangiocarcinoma | Schlermbhol Borntrakulpipat Apichat Sangchan Pisaln Mairiang Eimorn Mairiang Wattana Sukeepaisarnjaroen Kitti Chunlertrith Kookwan Sawadpanitch Tanita Suttichaimongkol Yupa Thawornpitak |
2016 | ||||
| 4. | Modified High Dose Omeprazole and Amoxicillin Triple Therapy Compare to Standard Triple Therapy in Helicobacter pylori Eradication | Uaepong Limpapanasit Pisaln Mairiang Kitti Chunlertlith Wattana Sukeepaisarnjaroen Suda Vannaprasaht Wichittra Tassaneeyakul Apichat Sangchan Kookwan Sawadpanich Tanita Suttichaimongkol |
2016 | ||||
| 5. | Outcomes of a randomized controlled trial comparing modified high dose omeprazole and amoxicillin triple therapy with standard triple therapy for helicobacter pylori eradication | Chunlertlith, K Limpapanasit, U Mairiang, P Vannaprasaht, S Tassaneeyakul, W Sangchan, A Sawadpanich, K Suttichaimongkol, T Pongpit, J Pattarapongsin, M |
2017 | ||||
| 6. | Economic evaluation of palliative biliary drainage in unresectable hilar cholangiocarcinoma | Sangchan, A. Mairiang, P. Mairiang, E. Sukeepaisarnjaroen, W. Chunlertlith, K. Sawadpanich, K. |
2018 | ||||
| 7. | The role of pegylated interferon and ribavirin in chronic hepatitis C genotype 3: A study of real-world practice in Southeast Asia | Sukeepaisarnjaroen, W. | 2018 | ||||
| 8. | Transient elastography for detecting significant liver fibrosis in Thai patients with chronic hepatitis C | Sangaimwibool , Sukeepaisarnjaroen, W. |
2018 | ||||
| 9. | Treatment outcomes and costs of pegylated interferon and ribavirin therapy in chronic hepatitis C virus infection | Sukeepaisarnjaroen, W. Sawanyawisuth, K. |
2018 | ||||
| 10. | A PROSPECTIVE, ENDOSCOPIST-BLINDED, RANDOMIZED, CONTROLLED TRIAL COMPARING BETWEEN TRIPLE DOSE AND SPLIT DOSE NIFLEC BOWEL PREPARATION BEFORE COLONOSCOPY IN CONSTIPATED PATIENTS | Alongkorn Chancharoen Pisaln Mairiang Kookwan Sawadpanich Tanita Suttichaimongkol Wichak Kunyakham Uaepong Limpapanasit Nitiwat Chansuk Schlermbhol Borntrakulpipat |
2019 | ||||
| 11. | Diagnostic performance and correlation of hepatitis C virus core antigen compared with hepatitis C virus RNA | Sukeepaisarnjaroen, W. | 2019 | ||||
| 12. | Prevalence and associated factors of small intestinal bacterial overgrowth among systemic sclerosis patients. | Sawadpanich, K. Chunlertrith, K. Mairiang, P. Sukeepaisarnjaroen, W. Sangchan, A. Foocharoen, C. |
2019 | ||||
| 13. | PROGNOSTIC FACTORS FOR REMISSION, RELAPSE AND TREATMENT COMPLICATIONS OF TYPE 1 AUTOIMMUNE HEPATITIS IN THAILAND | Nitipat Sandusadee Tanita Suttichaimongkol Wattana Sukeepaisarnjaroen |
2019 | ||||
| 14. | Triple-dose vs. Split-dose PEG-ELS bowel preparation before colonoscopy in constipated patients: A prospective, endoscopist-blinded, randomized controlled trial | Chancharoen, A. Mairiang, P. Sawadpanich, K. Kunyakham, W. |
2019 | ||||
| 15. | Diagnostic Performance of Fibrotest/Actitest for Staging Significant Liver Fibrosis in Thai Chronic Hepatitis C Patients | Tangvoraphonkchai, K. Sangaimwibool, P. Sukeepaisarnjaroen, W. |
2020 | ||||
| 16. | Prognostic factors for remission, relapse, and treatment complications in type 1 autoimmune hepatitis. | Nitipat Sandusadee Wattana Sukeepaisarnjaroen Tanita Suttichaimongkol |
2020 | ||||
| 17. | Association between hepatic steatosis and fibrosis in chronic viral hepatitis B and C patients | Kularbkaew, C. | 2021 | ||||
| 18. | Surveillance for hepatitis B virus seroprevalence nearly 30 years after the implementation of a national vaccination program. | Tanita Suttichaimongkol Chitchai Rattananukrom Arthit Wongsaensook Kittisak Sawanyawisuth Wattana Sukeepaisarnjaroen |
2021 | ||||
| 19. | Acute-on-chronic liver failure: Epidemiology, prognosis, and outcome of a multicenter study in Thai population. | Sukeepaisarnjaroen, W. | 2022 | ||||
| 20. | Application of Mac-2 binding protein glycosylation isomer as a non-invasive biomarker for probing liver disease. | Tangvoraphonkchai, K. Kularbkaew, C. Sangaimwibool, P. Sukeepaisarnjaroen, W. |
2022 | ||||
| 21. | A surveillance for hepatitis C virus infection in northeastern, Thailand: a 10-year cohort | Suttichaimongkol, T Rattananukrom, C Wongsaensook, A Sukeepaisarnjaroen, W Sawanyawisuth, K |
2022 | ||||
| 22. | Clinical versus radiographical factors associated with hepatocellular carcinoma diagnosis in high-risk patients: sizes matter | Suttichaimongkol, T Mitpracha, M Tangvoraphonkchai, K Sadee, P Sawanyawisuth, K Sukeepaisarnjaroen, W |
2022 | ||||
| 23. | Validation of prognostic scores predicting mortality in acute liver decompensation or acute-on-chronic liver failure: A Thailand multicenter study | Teerasarntipan, T Thanapirom, K Chirapongsathorn, S Suttichaimongkol, T Chamroonkul, N Bunchorntavakul, C Siramolpiwat, S Chainuvati, S Sobhonslidsuk, A Leerapun, A Piratvisuth, T Sukeepaisarnjaroen, W Tanwandee, T Treeprasertsuk, S |
2022 | ||||
| 24. | Incidence and Predictors of an Abnormal Liver Function Test Among 674 Systemic Sclerosis Patients: A Cohort Study. | Sawadpanich, K. Promasen, P. Mairiang, P. Sukeepaisarnjareon, W. Sangchan, A. Suttichaimongkol, T. Tangvoraphonkchai, K. Foocharoen, C. |
2023 | ||||
| 25. | PIVKA-II or AFP has better diagnostic properties for hepatocellular carcinoma diagnosis in high-risk patients. | Suttichaimongkol, T. Mitpracha, M. Tangvoraphonkchai, K. Sadee, P. Sawanyawisuth, K. Sukeepaisarnjaroen, W. |
2023 | ||||
| 26. | Characteristics, Clinical Outcomes, and Prognosis of Anal and Pouch-related Carcinoma in Patients With Crohn's Disease. | Suttichaimongkol, T Loftus, EV |
2024 | ||||
| 27. | Durvalumab with or without bevacizumab with transarterial chemoembolisation in hepatocellular carcinoma (EMERALD-1): a multiregional, randomised, double-blind, placebo-controlled, phase 3 study | Sangro, B Kudo, M Erinjeri, JP Qin, S Ren, Z Chan, SL Arai, Y Heo, J Mai, A Escobar, J Lopez Chuken, YA Yoon, JH Tak, WY Breder, VV Suttichaimongkol, T Bouattour, M Lin, SM Peron, JM Nguyen, QT Yan, L Chiu, CF Santos, FA Veluvolu, A Thungappa, SC Matos, M Żotkiewicz, M Udoye, SI Kurland, JF Cohen, GJ Lencioni, R , |
2025 | Count | 21 | 13 | 9 | 0 |
| Title | Authors | Year | Publication name | Cited count | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| < 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Total | ||||||
| 1. | The efficacy of topiramate in status epilepticus, experience from Thailand | Tiamkao, S. Sawanyawisuth, K. |
2012 |
Neurology Asia 4 (17), pp. 297-302 |
||||||||
| 2. | Outcomes of a randomized controlled trial comparing modified high dose omeprazole and amoxicillin triple therapy with standard triple therapy for helicobacter pylori eradication | Mairiang, P. Vannaprasaht, S. Tassaneeyakul, W. Sangchan, A. Sawadpanich, K. |
2017 |
Asian Pacific Journal of Cancer Prevention 4 (18), pp. 927-932 |
||||||||
| 3. | Economic evaluation of palliative biliary drainage in unresectable hilar cholangiocarcinoma | Sangchan, A. Mairiang, P. Mairiang, E. Sukeepaisarnjaroen, W. Chunlertlith, K. Sawadpanich, K. |
2018 |
Journal of the Medical Association of Thailand 4 (101), pp. S44-S52 |
||||||||
| 4. | The role of pegylated interferon and ribavirin in chronic hepatitis C genotype 3: A study of real-world practice in Southeast Asia | Sukeepaisarnjaroen, W. | 2018 |
Journal of the Medical Association of Thailand 7 (101), pp. S167-S172 |
||||||||
| 5. | Transient elastography for detecting significant liver fibrosis in Thai patients with chronic hepatitis C | Sangaimwibool , Sukeepaisarnjaroen, W. |
2018 |
Journal of the Medical Association of Thailand 4 (101), pp. S66-S71 |
||||||||
| 6. | Treatment outcomes and costs of pegylated interferon and ribavirin therapy in chronic hepatitis C virus infection | Sukeepaisarnjaroen, W. Sawanyawisuth, K. |
2018 |
Journal of the Medical Association of Thailand 4 (101), pp. S80-S86 |
||||||||
| 7. | Diagnostic performance and correlation of hepatitis C virus core antigen compared with hepatitis C virus RNA | Sukeepaisarnjaroen, W. | 2019 |
Journal of the Medical Association of Thailand 12 (102), pp. 75-80 |
||||||||
| 8. | Prevalence and associated factors of small intestinal bacterial overgrowth among systemic sclerosis patients | Sawadpanich, K. Chunlertrith, K. Mairiang, P. Sukeepaisarnjaroen, W. Sangchan, A. Foocharoen, C. |
2019 |
International Journal of Rheumatic Diseases 4 (22), pp. 695-699 |
||||||||
| 9. | Triple-dose vs. Split-dose PEG-ELS bowel preparation before colonoscopy in constipated patients: A prospective, endoscopist-blinded, randomized controlled trial | Chancharoen, A. Mairiang, P. Sawadpanich, K. Kunyakham, W. |
2019 |
Journal of the Medical Association of Thailand 12 (102), pp. 113-119 |
||||||||
| 10. | Diagnostic Performance of Fibrotest/Actitest for Staging Significant Liver Fibrosis in Thai Chronic Hepatitis C Patients | Tangvoraphonkchai, K. Sangaimwibool, P. Sukeepaisarnjaroen, W. |
2020 |
Journal of the Medical Association of Thailand 12 (103), pp. |
||||||||
| 11. | Prognostic factors for remission, relapse, and treatment complications in type 1 autoimmune hepatitis | Sukeepaisarnjaroen, W. | 2020 |
Heliyon 4 (6), pp. |
||||||||
| 12. | Association between hepatic steatosis and fibrosis in chronic viral hepatitis B and C patients | Kularbkaew, C. | 2021 |
Journal of the Medical Association of Thailand 3 (104), pp. 396-401 |
||||||||
| 13. | Surveillance for hepatitis b virus seroprevalence nearly 30 years after the implementation of a national vaccination program | Wongsaensook, A. Sukeepaisarnjaroen, W. |
2021 |
GERMS 3 (11), pp. 403-407 |
||||||||
| 14. | Acute-on-chronic liver failure: Epidemiology, prognosis, and outcome of a multicenter study in Thai population | Sukeepaisarnjaroen, W. | 2022 |
JGH Open 3 (6), pp. 205-212 |
||||||||
| 15. | Application of Mac-2 binding protein glycosylation isomer as a non-invasive biomarker for probing liver disease | Tangvoraphonkchai, K. Kularbkaew, C. Sangaimwibool, P. Sukeepaisarnjaroen, W. |
2022 |
Scientific Reports 1 (12), pp. |
||||||||
| 16. | A surveillance for hepatitis C virus infection in northeastern, Thailand: a 10-year cohort | Suttichaimongkol, T. Rattananukrom, C. Wongsaensook, A. Sukeepaisarnjaroen, W. Sawanyawisuth, K. |
2022 |
Journal of Preventive Medicine and Hygiene 2 (63), pp. E288-E291 |
||||||||
| 17. | Clinical versus radiographical factors associated with hepatocellular carcinoma diagnosis in high-risk patients: sizes matter | Tangvoraphonkchai, K. Sadee, P. Sukeepaisarnjaroen, W. |
2022 |
Future Science OA 4 (8), pp. |
||||||||
| 18. | Validation of prognostic scores predicting mortality in acute liver decompensation or acute-on-chronic liver failure: A Thailand multicenter study | Teerasarntipan, T. Thanapirom, K. Chirapongsathorn, S. Suttichaimongkol, T. Chamroonkul, N. Bunchorntavakul, C. Siramolpiwat, S. Chainuvati, S. Sobhonslidsuk, A. Leerapun, A. Piratvisuth, T. Sukeepaisarnjaroen, W. Tanwandee, T. Treeprasertsuk, S. |
2022 |
PLoS ONE 11 November (17), pp. |
||||||||
| 19. | Incidence and Predictors of an Abnormal Liver Function Test Among 674 Systemic Sclerosis Patients: A Cohort Study | Sawadpanich, K. Promasen, P. Mairiang, P. Sukeepaisarnjareon, W. Sangchan, A. Suttichaimongkol, T. Tangvoraphonkchai, K. Foocharoen, C. |
2023 |
Open Access Rheumatology: Research and Reviews (15), pp. 81-92 |
||||||||
| 20. | PIVKA-II or AFP has better diagnostic properties for hepatocellular carcinoma diagnosis in high-risk patients | Suttichaimongkol, T. Mitpracha, M. Tangvoraphonkchai, K. Sadee, P. Sawanyawisuth, K. Sukeepaisarnjaroen, W. |
2023 |
Journal of Circulating Biomarkers (12), pp. 12-16 |
||||||||
| 21. | Durvalumab with or without bevacizumab with transarterial chemoembolisation in hepatocellular carcinoma (EMERALD-1): a multiregional, randomised, double-blind, placebo-controlled, phase 3 study | Sangro, B. Kudo, M. Erinjeri, J.P. Qin, S. Ren, Z. Chan, S.L. Arai, Y. Heo, J. Mai, A. Escobar, J. Lopez Chuken, Y.A. Yoon, J.H. Tak, W.Y. Breder, V.V. Suttichaimongkol, T. Bouattour, M. Lin, S.M. Peron, J.M. Nguyen, Q.T. Yan, L. Chiu, C.F. Santos, F.A. Veluvolu, A. Thungappa, S.C. Matos, M. Żotkiewicz, M. Udoye, S.I. Kurland, J.F. Cohen, G.J. Lencioni, R. |
2025 |
Lancet 10474 (405), pp. 216-232 |
||||||||
| Title | Authors | Year | Journal title | ||
|---|---|---|---|---|---|
| 1. | Outcomes of a Randomized Controlled Trial Comparing Modified High Dose Omeprazole and Amoxicillin Triple Therapy with Standard Triple Therapy for Helicobacter Pylori Eradication | Chunlertlith, K Limpapanasit, U Mairiang, P Vannaprasaht, S Tassaneeyakul, W Sangchan, A Sawadpanich, K Suttichaimongkol, T Pongpit, J Pattarapongsin, M |
2017 |
Asian Pacific journal of cancer prevention : APJCP 4 (18), pp. 927-932 |
|
| 2. | Prevalence and associated factors of small intestinal bacterial overgrowth among systemic sclerosis patients. | Sawadpanich, K Soison, P Chunlertrith, K Mairiang, P Sukeepaisarnjaroen, W Sangchan, A Suttichaimongkol, T Foocharoen, C |
2019 |
International journal of rheumatic diseases 4 (22), pp. 695-699 |
|
| 3. | Prognostic factors for remission, relapse, and treatment complications in type 1 autoimmune hepatitis. | Sandusadee, N Sukeepaisarnjaroen, W Suttichaimongkol, T |
2020 |
Heliyon 4 (6), pp. e03767 |
|
| 4. | Surveillance for hepatitis B virus seroprevalence nearly 30 years after the implementation of a national vaccination program. | Suttichaimongkol, T Rattananukrom, C Wongsaensook, A Sawanyawisuth, K Sukeepaisarnjaroen, W |
2021 |
Germs 3 (11), pp. 403-407 |
|
| 5. | Validation of prognostic scores predicting mortality in acute liver decompensation or acute-on-chronic liver failure: A Thailand multicenter study. | Teerasarntipan, T Thanapirom, K Chirapongsathorn, S Suttichaimongkol, T Chamroonkul, N Bunchorntavakul, C Siramolpiwat, S Chainuvati, S Sobhonslidsuk, A Leerapun, A Piratvisuth, T Sukeepaisarnjaroen, W Tanwandee, T Treeprasertsuk, S |
2022 |
PloS one 11 (17), pp. e0277959 |
|
| 6. | Acute-on-chronic liver failure: Epidemiology, prognosis, and outcome of a multicenter study in Thai population. | Chirapongsathorn, S Teerasarntipan, T Tipchaichatta, K Suttichaimongkol, T Chamroonkul, N Bunchorntavakul, C Siramolpiwat, S Chainuvati, S Sobhonslidsuk, A Leerapun, A Piratvisuth, T Sukeepaisarnjaroen, W Tanwandee, T Treeprasertsuk, S |
2022 |
JGH open : an open access journal of gastroenterology and hepatology 3 (6), pp. 205-212 |
|
| 7. | Clinical versus radiographical factors associated with hepatocellular carcinoma diagnosis in high-risk patients: sizes matter. | Suttichaimongkol, T Mitpracha, M Tangvoraphonkchai, K Sadee, P Sawanyawisuth, K Sukeepaisarnjaroen, W |
2022 |
Future science OA 4 (8), pp. FSO785 |
|
| 8. | Application of Mac-2 binding protein glycosylation isomer as a non-invasive biomarker for probing liver disease. | Tangvoraphonkchai, K Suttichaimongkol, T Kularbkaew, C Sangaimwibool, P Sukeepaisarnjaroen, W |
2022 |
Scientific reports 1 (12), pp. 6757 |
|
| 9. | A surveillance for hepatitis C virus infection in northeastern, Thailand: a 10-year cohort. | Suttichaimongkol, T Rattananukrom, C Wongsaensook, A Sukeepaisarnjaroen, W Sawanyawisuth, K |
2022 |
Journal of preventive medicine and hygiene 2 (63), pp. E288-E291 |
|
| 10. | PIVKA-II or AFP has better diagnostic properties for hepatocellular carcinoma diagnosis in high-risk patients. | Suttichaimongkol, T Mitpracha, M Tangvoraphonkchai, K Sadee, P Sawanyawisuth, K Sukeepaisarnjaroen, W |
2023 |
Journal of circulating biomarkers (12), pp. 12-16 |
|
| 11. | Incidence and Predictors of an Abnormal Liver Function Test Among 674 Systemic Sclerosis Patients: A Cohort Study. | Sawadpanich, K Promasen, P Mairiang, P Sukeepaisarnjareon, W Sangchan, A Suttichaimongkol, T Tangvoraphonkchai, K Foocharoen, C |
2023 |
Open access rheumatology : research and reviews (15), pp. 81-92 |
|
| 12. | Characteristics, Clinical Outcomes, and Prognosis of Anal and Pouch-related Carcinoma in Patients With Crohn's Disease. | Suttichaimongkol, T Loftus, EV |
2024 |
Inflammatory bowel diseases 4 (30), pp. 547-553 |
|
| 13. | Durvalumab with or without bevacizumab with transarterial chemoembolisation in hepatocellular carcinoma (EMERALD-1): a multiregional, randomised, double-blind, placebo-controlled, phase 3 study. | Sangro, B Kudo, M Erinjeri, JP Qin, S Ren, Z Chan, SL Arai, Y Heo, J Mai, A Escobar, J Lopez Chuken, YA Yoon, JH Tak, WY Breder, VV Suttichaimongkol, T Bouattour, M Lin, SM Peron, JM Nguyen, QT Yan, L Chiu, CF Santos, FA Veluvolu, A Thungappa, SC Matos, M Żotkiewicz, M Udoye, SI Kurland, JF Cohen, GJ Lencioni, R , |
2025 |
Lancet (London, England) 10474 (405), pp. 216-232 |
| Title | Authors | Year | Journal title | Cited count | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| < 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Total | ||||||
| 1. | The efficacy of topiramate in status epilepticus, experience from Thailand | Tanita Suttichaimongkol Somsak Tiamkao Kittisak Sawanyawisuth |
2012 |
NEUROLOGY ASIA 4.0 (17.0), pp. 297.0-302.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 2. | Cost Utility Analysis of Biliary Drainage and Palliative Care in Unresectable Hilar Cholangiocarcinoma: Decision Analytic Modeling Approach | Tanita Suttichaimongkol Apichat Sangchan Pisaln Mairiang |
2015 |
GASTROINTESTINAL ENDOSCOPY 5.0 (81.0), pp. AB363-AB363 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 3. | Cost utility analysis of palliative biliary drainage compare with palliative care in unresectable hilar cholangiocarcinoma | Schlermbhol Borntrakulpipat Apichat Sangchan Pisaln Mairiang Eimorn Mairiang Wattana Sukeepaisarnjaroen Kitti Chunlertrith Kookwan Sawadpanitch Tanita Suttichaimongkol Yupa Thawornpitak |
2016 |
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (31.0), pp. 228.0-229.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 4. | Modified High Dose Omeprazole and Amoxicillin Triple Therapy Compare to Standard Triple Therapy in Helicobacter pylori Eradication | Uaepong Limpapanasit Pisaln Mairiang Kitti Chunlertlith Wattana Sukeepaisarnjaroen Suda Vannaprasaht Wichittra Tassaneeyakul Apichat Sangchan Kookwan Sawadpanich Tanita Suttichaimongkol |
2016 |
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (31.0), pp. 78.0-78.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 5. | A PROSPECTIVE, ENDOSCOPIST-BLINDED, RANDOMIZED, CONTROLLED TRIAL COMPARING BETWEEN TRIPLE DOSE AND SPLIT DOSE NIFLEC BOWEL PREPARATION BEFORE COLONOSCOPY IN CONSTIPATED PATIENTS | Alongkorn Chancharoen Pisaln Mairiang Kookwan Sawadpanich Tanita Suttichaimongkol Wichak Kunyakham Uaepong Limpapanasit Nitiwat Chansuk Schlermbhol Borntrakulpipat |
2019 |
GASTROINTESTINAL ENDOSCOPY 6.0 (89.0), pp. AB517-AB517 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 6. | Prevalence and associated factors of small intestinal bacterial overgrowth among systemic sclerosis patients | Kookwan Sawadpanich Pisit Soison Kitti Chunlertrith Pisaln Mairiang Wattana Sukeepaisarnjaroen Apichat Sangchan Tanita Suttichaimongkol Chingching Foocharoen |
2019 |
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES 4.0 (22.0), pp. 695.0-699.0 |
9 | 0 | 0 | 0 | 0 | 0 | 9 | |
| 7. | PROGNOSTIC FACTORS FOR REMISSION, RELAPSE AND TREATMENT COMPLICATIONS OF TYPE 1 AUTOIMMUNE HEPATITIS IN THAILAND | Nitipat Sandusadee Tanita Suttichaimongkol Wattana Sukeepaisarnjaroen |
2019 |
GASTROENTEROLOGY 6.0 (156.0), pp. S1356-S1356 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 8. | Prognostic factors for remission, relapse, and treatment complications in type 1 autoimmune hepatitis | Nitipat Sandusadee Wattana Sukeepaisarnjaroen Tanita Suttichaimongkol |
2020 |
HELIYON 4.0 (6.0), pp. |
2 | 0 | 0 | 0 | 0 | 0 | 2 | |
| 9. | Surveillance for hepatitis B virus seroprevalence nearly 30 years after the implementation of a national vaccination program | Tanita Suttichaimongkol Chitchai Rattananukrom Arthit Wongsaensook Kittisak Sawanyawisuth Wattana Sukeepaisarnjaroen |
2021 |
GERMS 3.0 (11.0), pp. 403.0-407.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Title | Authors | Year | Journal title |
|---|
| Title | Authors | NRIIS type | Year | NRIIS Scholarship |
|---|